arrow
W

Wen Ye

Eli Lilly and Co
H指数:28
被引数:2,463

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dynamic postoperative prognosis and follow-up optimization for gastric cancer patients after neoadjuvant therapy: a multicenter retrospective study

胃癌新辅助治疗后患者的动态术后预后及随访优化:一项多中心回顾性研究

2025-10-020
PRE
Obox1 deficiency impairs fertility in female mice

Obox1 缺失损害雌性小鼠的生育能力

2025-04-190
OAAI
Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease
2022-11-036
OA
Chitosan-Gelatin-EGCG Nanoparticle-Meditated LncRNA TMEM44-AS1 Silencing to Activate the P53 Signaling Pathway for the Synergistic Reversal of 5-FU Resistance in Gastric Cancer

壳聚糖-明胶-EGCG纳米粒介导LncRNA TMEM44-AS1沉默激活P53信号通路协同逆转胃癌5-FU耐药

2022-06-1948
OAAI
Old targets, new strategy: Apigenin-7-O-β-d-(-6-p-coumaroyl)-glucopyranoside prevents endothelial ferroptosis and alleviates intestinal ischemia-reperfusion injury through HO-1 and MAO-B inhibition

老靶点,新策略: 芹菜素-7-o-β-d-(-6-对香豆酰)-吡喃葡萄糖苷通过HO-1和mao-b抑制作用预防内皮细胞铁死亡并减轻肠缺血再灌注损伤

2022-05-0124
PRE